Compare Match Group Inc (MTCH) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Match Group Inc vs Neurocrine Biosciences Inc — how do they compare? Match Group Inc trades at $39.02 (market cap $9.10B), while Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B). The key difference: Neurocrine Biosciences Inc is the larger of the two by market cap, and Match Group Inc pays a 2.05% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| MTCH | NBIX | |
|---|---|---|
Market Cap | $9.10B | $17.40B |
Sector | Media | Health |
52-Week High | $40.29 | $180.55 |
52-Week Low | $28.90 | $123.10 |
Enterprise Value | $12.05B | $16.49B |
Dividend Yield | 2.05% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
